Cypherpunk Technologies Inc. focuses on pursuing a digital asset strategy by accumulating ZEC , a privacy coin tied to the Zcash network. Cypherpunk Technologies Inc. , formerly known as Leap Therapeutics, is based in Cambridge, Massachusetts.
| Revenue (Most Recent Fiscal Year) | -- |
| Net Income (Most Recent Fiscal Year) | $4.82M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.52 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -- |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -48.33% |
| Return on Assets (Trailing 12 Months) | -42.21% |
| Current Ratio (Most Recent Fiscal Quarter) | 27.28 |
| Quick Ratio (Most Recent Fiscal Quarter) | 27.28 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.79 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.02 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 106.46M |
| Free Float | 102.74M |
| Market Capitalization | $139.47M |
| Average Volume (Last 20 Days) | 4.61M |
| Beta (Past 60 Months) | -0.09 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 3.50% |
| Percentage Held By Institutions (Latest 13F Reports) | 30.46% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |